A small subset of CD133+ cells that also exhibited the chemokine receptor CXCR4 induced the formation of primary tumors and metastases in mice, a pancreatic cancer study revealed. Researchers also found that CD133-marked cancer stem cells are resistant to chemotherapeutics and said that the findings could have implications for other tumors.

Related Summaries